From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify patterns of neurodegeneration and create metrics ...

Submitted research has nearly doubled to a record-breaking 460 abstracts for the 9th Asian and Oceanian Parkinson's Disease and Movement Disorders Congress (AOPMC). "The depth of novel insights that ...

From a study that analyzed brain images of more than 2,500 people with Parkinson's disease in 20 different countries, scientists were able to identify ...

February is American Heart Month and the American College of Emergency Physicians (ACEP) has tips to help you spot signs of a heart attack and know when it is time to go to the emergency ...

For children with signs of neurological conditions such as autism, epilepsy and global developmental delay, genetic testing can help make the diagnosis, identify possible treatments and determine ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

AI predicts Parkinson’s disease using medical and prescription data, enhancing early diagnosis and research into new ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) ...

Law professors and engineers take their bows, while a retired environmental scientist is the area’s top gardener.

Ventyx Biosciences Inc. (VTYX) stock has reached a 52-week low, trading at $1.57, marking a significant downturn for the biopharmaceutical company. With a market capitalization of $114.5 million, the ...